Nakamura N, Kusunoki Y, Akiyama M
Department of Radiobiology, Radiation Effects Research Foundation, Hiroshima, Japan.
Radiat Res. 1990 Aug;123(2):224-7.
The recent development of an in vitro lymphocyte colony assay makes it possible to examine variations in the radiosensitivity of humans using peripheral blood lymphocytes (PBL) instead of the skin fibroblast assay. Our recent study (M. Hakoda et al., Mutat. Res. 197, 161-169, 1988) showed that most of the colonies consisted of lymphocytes bearing CD4 or CD8 antigens. Since the fraction of CD4+ and CD8+ cells in PBL differs among individuals, we suspected that individual radiosensitivity might be biased by the different subset frequencies if the dose-survival curves of the CD4+ and CD8+ cells were different from each other. In the present study, CD4+ (helper/inducer T) and CD8+ (suppressor/cytotoxic T) lymphocytes were isolated from PBL and their dose-survival curves were determined. The results showed that the D10 (dose required to reduce the surviving fraction to 10%) was similar for these two types of cells [3.13 +/- 0.10 Gy (mean +/- SD) for CD4+, 3.34 +/- 0.50 Gy for CD8+ and 3.14 +/- 0.17 Gy for the unsorted cells], supporting the use of the whole PBL population for the screening of individuals with altered radiosensitivity.
体外淋巴细胞集落测定法的最新进展使得利用外周血淋巴细胞(PBL)而非皮肤成纤维细胞测定法来检测人类放射敏感性的变化成为可能。我们最近的研究(M. Hakoda等人,《突变研究》197, 161 - 169, 1988)表明,大多数集落由带有CD4或CD8抗原的淋巴细胞组成。由于PBL中CD4 +和CD8 +细胞的比例在个体之间存在差异,我们怀疑如果CD4 +和CD8 +细胞的剂量存活曲线彼此不同,个体放射敏感性可能会因不同的亚群频率而产生偏差。在本研究中,从PBL中分离出CD4 +(辅助/诱导性T)和CD8 +(抑制/细胞毒性T)淋巴细胞,并测定它们的剂量存活曲线。结果表明,这两种类型细胞的D10(将存活分数降低至10%所需的剂量)相似[CD4 +细胞为3.13 +/- 0.10 Gy(平均值 +/- 标准差),CD8 +细胞为3.34 +/- 0.50 Gy,未分选细胞为3.14 +/- 0.17 Gy],这支持了使用整个PBL群体来筛选放射敏感性改变的个体。